Designing and development of a silencer vector based on second generation of RNA interference (RNAi) technique to study downregulation of steroid receptor RNA activator (SRA)

سال انتشار: 1388
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 182

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_PRJMS-12-3_004

تاریخ نمایه سازی: 28 بهمن 1403

چکیده مقاله:

Objective: RNA interference (RNAi) is the most potent technique for gene silencing in eukaryotic cellular system at transcriptomic level. Genetic disorders and cancers are important targets for therapeutic development of this technique. In order to bypass the temporary dpwnregulation by siRNA, a new generation of shRNA named shRNAmir has developed. Silencing construct with structure similar to microRNA (shRNAmir), mimics a natural microRNA pathway inside the cell. Steroid receptor RNA activator (SRA) is one of the regulators of steroid receptor like ER. Prostate, uterus and breast tissue express a low level of SRA, there is an increase of expression during their tumorgenesis. So SRA may participate in tumorgenesis or proliferation of tumors. Materials and Methods: We used RNAi technique to silence expression of SRA. The SRA silencer was designed and constructed by Soe-PCR, then cloned into an expression vector pEGFPC۱. Human breast cancer (MCF۷) cells were transfected with silencer plasmid then the changes in the SRA expression estimated by Real-Time PCR at ۲۴, ۷۲ hours and after ۱۰days. Result: The results showed about ۶۰% decrease in relative expression of SRA gene, after ۷۲ hours and ۱۰ days, which shows that shRNAmir–SRA could successfully knockdown the expression of target gene. Conclusion: It seems that the designed shRNAmir may be a suitable tool for a variety of applications because it could stably knockdown the expression of target gene.

کلیدواژه ها:

shRNAmir ، RNA interference ، Steroid receptor RNA activator (SRA) ، Breast Cancer ، RNA تداخلگر ، کمک فعالکننده گیرنده استروئیدی (SRA) ، سرطان پستان

نویسندگان

مهدی فروزنده

Department of Medical Biotechnology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran

سعیده عسکریان

Department of Medical Biotechnology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran

لیدا لنگرودی

گروه بیوتکنولوژی پزشکی، دانشکده علوم پزشکی، دانشگاه تربیت مدرس، تهران، ایران

فاطمه رهبریزاده

گروه بیوتکنولوژی پزشکی، دانشکده علوم پزشکی، دانشگاه تربیت مدرس، تهران، ایران